Microglia-Specific K2P Channel THIK-1: Structure, Function, and Therapeutic Potential.
This review integrates structural (cryo-EM), electrophysiological, and functional evidence that the microglia-enriched K2P channel THIK-1 controls membrane potential, surveillance motility, synaptic pruning, and NLRP3 inflammasome–dependent pyroptosis, and argues THIK-1 is a druggable…
What the AI sees
This review integrates structural (cryo-EM), electrophysiological, and functional evidence that the microglia-enriched K2P channel THIK-1 controls membrane potential, surveillance motility, synaptic pruning, and NLRP3 inflammasome–dependent pyroptosis, and argues THIK-1 is a druggable…
Research significance
THIK-1 links microglial bioelectric regulation to NLRP3-mediated neuroinflammation, is structurally characterized for small-molecule targeting, and thus represents a promising, microglia-specific therapeutic entry point to modulate inflammation-driven Parkinson's disease processes.
Source abstract
BACKGROUND: The tandem pore domain halothane-inhibited potassium (THIK-1) channel is a member of the two-pore domain potassium (K2P) channel family and plays a critical role in maintaining the resting membrane potential. THIK-1 has emerged as a key regulator of microglial physiology and neuroimmune signaling. With the rapid accumulation of structural, electrophysiological, and functional evidence, there is an increasing need for an integrated understanding of THIK-1 in the context of microglial biology and disease. AIMS: This review provides a comprehensive synthesis of the structural, regulatory, and functional properties of THIK-1, with a particular focus on its roles in microglial physiology, neuroimmune signaling, and central nervous system (CNS) pathologies. MATERIALS AND METHODS: We conducted a comprehensive review of recent literature, including electrophysiological, molecular, and structural studies, with particular emphasis on cryo-electron microscopy findings, pharmacological modulation, and disease-associated functional analyses. RESULTS: THIK-1 is selectively enriched in microglia and contributes to essential cellular processes, including surveillance motility, synaptic pruning, and inflammasome activation. Its high constitutive activity makes it a dominant determinant of the microglial membrane potential. Structural studies have identified key features, including a lipid-interacting pocket and a cytoplasmic gate, which underlie lipid- and anesthetic-mediated regulation. Functionally, THIK-1-mediated K⁺ efflux is required for NOD-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome activation and pyroptosis. Accumulating evidence links THIK-1 to major CNS disorders, including neuroinflammation, neurodegeneration (e.g., Alzheimer's and Parkinson's diseases), and psychiatric disorders. DISCUSSION: The convergence of structural, electrophysiological, and immunological findings positions THIK-1 as a central regulator of neuroimmune signaling. Integration of these findings provides new insights into how ion channel activity shapes microglial function and disease processes. CONCLUSION: THIK-1 represents a critical nexus between ion channel biophysics and neuroimmune dysfunction. A comprehensive understanding of its regulation and function supports its potential as a microglia-specific therapeutic target in neuroinflammatory and neurodegenerative disorders.